RxDoctor Payments Data

Bruce Larsen, MD

Family Medicine · Farr West, UTNPI 1922189372

Payments from drug & device makers

$1,586in general payments, 2019–2025

Across 99 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$442
  • Amgen$155
  • Pfizer$112
  • AstraZeneca$88
  • Merck$81
  • Axsome Therapeutics, Inc.$73
  • plus $636 from 19 others

What the payments were for

  • Food & beverage$1,586100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,586 in reported general payments places this provider in the 65th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$153,700
Medicare patients
283
Services billed
3,279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol53$73,965
EliquisApixaban63$73,709
JardianceEmpagliflozin54$71,811
XareltoRivaroxaban23$39,352
TrulicityDulaglutide16$33,149
OzempicSemaglutide23$27,258
MounjaroTirzepatide25$24,491
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$20,254
MyrbetriqMirabegron13$16,718
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$12,929
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$10,770
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$7,667
Humalog Kwikpen U-100Insulin Lispro19$7,421
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$7,216
JanuviaSitagliptin Phosphate12$6,548

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$88$94,21975 claims
PfizerEliquis$112$73,70963 claims
Lilly USA, LLCTrulicity, Mounjaro$52$57,64141 claims
Johnson & JohnsonXarelto$17$39,35223 claims
Novo NordiskOzempic$55$27,25823 claims
Astellas Pharma US IncMyrbetriq$33$16,71813 claims
GSKTrelegy Ellipta$69$10,77013 claims
MerckJanuvia$81$6,54812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 928 family medicine providers in Utah.

Other family medicine in Farr West

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →